Four executive officers, two of whom are also directors, of Bowman Consulting Group Ltd. (the “Company”) have entered into, or modified, written stock trading plans pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (each a “10b5-1 Plan”) and the Company’s insider trading policy.
On December 13, 2022, Michael Bruen, the Company’s Chief Operating Officer, and Director, terminated his existing 10b5-1Plan, which was entered into on May 19, 2022 and related the sales of up to 30,000 shares of Company common stock from December 2022 through November 2023. Mr. Bruen entered into a new 10b5-1 Plan on December 13, 2022 related to the sales of up to 46,000 shares of Company common stock. Subject to the terms and conditions of this plan, a brokerage firm may periodically effect the transactions from January 2023 through August 2023.
On December 13, 2022, Bruce Labovitz, the Company’s Chief Financial Officer, entered into a 10b5-1 Plan related to the sales of up to 9,000 shares of Company common stock. Subject to the terms and conditions of this plan, a brokerage firm may periodically effect the transactions from March 2023 through May 2023. Mr. Labovitz’s existing 10b5-1 Plan, which was entered into on May 23, 2022 and relates to the sales of up to 7,000 shares of Company common stock, expires at the end of December 2022.
On December 16, 2022, Robert Hickey, the Company’s Chief Legal Officer and Secretary, entered into a 10b5-1 Plan related to the sales of up to 32,000 shares of Company common stock. Subject to the terms and conditions of this plan, a brokerage firm may periodically effect the transactions from June 2023 through May 2024. Mr. Hickey’s existing 10b-5-1 Plan, which was entered into on November 30, 2021 and relates to the sale of up to 20,000 shares of Company common stock, expires in May 2023.
On December 16, 2022, Gary Bowman, the Company’s Chief Executive Officer, President and Director, entered into an amendment to his 10b5-1 Plan dated May 31, 2022, which relates to the sales of up to 30,000 shares of Company common stock. Under the amendment, the term of this plan was extended from August 2023 to December 2023 and an additional 50,000 shares of common stock of the Company may be ratably sold by brokerage firm from March 2023 through December 2023.
Transactions under each of the 10b5-1 Plans will be reported to the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations, to the extent applicable.